NLRP3 and pulmonary arterial hypertension: Moreover, our results suggest that ARC may attenuate the progression of MCT-induced PAH by reducing the expression of inflammatory cytokines, inhibiting the proliferation of pulmonary arterial smooth muscle cells, decreasing oxidative stress, and downregulating the NLRP3 signal pathway in lungs.